FRAUD/ABUSE
1.The Food and Drug Administration’s new policy proposal on repackaging drugs is being met with great opposition by the Long Term Care industry. The proposed policy puts new regulations on re-packaging time frames and where the packing takes place, creating a direct impact on the standard level of care required by Medicare and Medicaid. The CEO of the Senior Care Pharmacy Coalition submitted a detailed analysis and opposition letter to the FDA for consideration when drafting the final new policy provisions.
See following link: http://seniorcarepharmacies.org/wp-content/uploads/2015/12/SCPC-Letter-to-Jane-Axelrad-12-22-15.pdf
